| Schedule of Adjusted Condensed Cash Flow Statement |
The following table reflects the affected line items of the Condensed Consolidated Statements of Cash Flows and the adjustments to restated amounts. Net cash provided by financing activities; decrease in cash and cash equivalents; and cash and cash equivalents are also included to clarify that no restatement adjustments were made to those line items. The adjustments are as follows (in thousands):
|
|
Six Months Ended June 30, 2015
|
|
|
|
As Previously Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Condensed Consolidated Cash Flows (W&T including subsidiaries):
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable, accrued liabilities and other
|
|
(70,862
|
)
|
|
|
50,849
|
|
|
|
(20,013
|
)
|
|
Net cash provided by operating activities
|
|
30,061
|
|
|
|
50,849
|
|
|
|
80,910
|
|
|
Changes in operating assets and liabilities associated with investing activities
|
|
—
|
|
|
|
(50,849
|
)
|
|
|
(50,849
|
)
|
|
Net cash used in investing activities
|
|
(151,703
|
)
|
|
|
(50,849
|
)
|
|
|
(202,552
|
)
|
|
Net cash provided by financing activities
|
|
103,647
|
|
|
|
—
|
|
|
|
103,647
|
|
|
Decrease in cash and cash equivalents
|
|
(17,995
|
)
|
|
|
—
|
|
|
|
(17,995
|
)
|
|
Cash and cash equivalents, end of period
|
|
5,671
|
|
|
|
—
|
|
|
|
5,671
|
|
The following tables reflect the affected line items of the Condensed Consolidating Statements of Cash Flows contained within Note 12 – Supplemental Guarantor Information, and the adjustments to restated amounts. Net cash provided by financing activities; decrease in cash and cash equivalents; and cash and cash equivalents are also included to clarify that no restatement adjustments were made to those line items. The adjustments are as follows (in thousands):
|
|
Six Months Ended June 30, 2015
|
|
|
|
As Previously Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Condensed Consolidating Cash Flows (Parent Company):
|
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid expenses and other assets
|
|
(8,913
|
)
|
|
|
(22,178
|
)
|
|
|
(31,091
|
)
|
|
Accounts payable, accrued liabilities and other
|
|
(125,219
|
)
|
|
|
50,849
|
|
|
|
(74,370
|
)
|
|
Net cash used in operating activities
|
|
(94,175
|
)
|
|
|
28,671
|
|
|
|
(65,504
|
)
|
|
Changes in operating assets and liabilities associated with investing activities
|
|
-
|
|
|
|
(28,671
|
)
|
|
|
(28,671
|
)
|
|
Net cash used in investing activities
|
|
(27,467
|
)
|
|
|
(28,671
|
)
|
|
|
(56,138
|
)
|
|
Net cash provided by financing activities
|
|
103,647
|
|
|
|
—
|
|
|
|
103,647
|
|
|
Decrease in cash and cash equivalents
|
|
(17,995
|
)
|
|
|
—
|
|
|
|
(17,995
|
)
|
|
Cash and cash equivalents, end of period
|
|
5,671
|
|
|
|
-
|
|
|
|
5,671
|
|
|
|
Six Months Ended June 30, 2015
|
|
|
|
As Previously Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Condensed Consolidating Cash Flows (Energy VI):
|
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid expenses and other assets
|
|
72,712
|
|
|
|
22,178
|
|
|
|
94,890
|
|
|
Net cash provided by operating activities
|
|
124,236
|
|
|
|
22,178
|
|
|
|
146,414
|
|
|
Changes in operating assets and liabilities associated with investing activities
|
|
—
|
|
|
|
(22,178
|
)
|
|
|
(22,178
|
)
|
|
Net cash used in investing activities
|
|
(125,681
|
)
|
|
|
(22,178
|
)
|
|
|
(147,859
|
)
|
|
Net cash provided by financing activities
|
|
1,445
|
|
|
|
—
|
|
|
|
1,445
|
|
|
Decrease in cash and cash equivalents
|
|
-
|
|
|
|
—
|
|
|
|
-
|
|
|
Cash and cash equivalents, end of period
|
|
-
|
|
|
|
—
|
|
|
|
-
|
|
|